GENE ONLINE|News &
Opinion
Blog

2021-09-22| PartnerTechnology

Taiwan’s AMS BioteQ Develops a New Antimicrobial Dressing Which Accelerates Diabetes Wound Healing

by Tyler Chen
Share To

Wound dressing can provide more than protection in chronic wound care. With the right material and antimicrobial properties, a dressing can bolster wound recovery and effectively supplement the treatment, especially for diabetes.

Challenges of Diabetes Wounds

 

Studies have shown patients with diabetes have a 10% rate of developing diabetic foot ulcers, and 25% of diabetic patients are admitted to hospital due to foot illnesses. Those patients have high blood sugar, which causes bad blood circulation, weakens white blood cells and increases the number of bacteria. Therefore, they have slow recovery rates and cannot generate enough immunity to combat infection. It’s also hard for treatments to get into the wound.

To accelerate the healing, Taiwan’s Anti-Microbial Savior BioteQ Co., Ltd. (AMS BioteQ) has developed a new antimicrobial dressing for chronic wounds. This dressing is called MEDIACE®. It utilizes the antimicrobial property AirAce extracted from medicinal fungi using the proprietary technology ExtrO. The use of AirAce separates itself from other wound dressings on the market, which implement silver ions for the antimicrobial effect.

Comparison in different brands
Comparison in different brands

No Side Effects So Far in Animal Models

 

Dressings with silver ions take up most of the market, but trials have shown that these dressings can cause redness and allergy when applied to certain types of wounds. Meanwhile, MEDIACE® has demonstrated a positive response in animal models with diabetes and has no side effects so far, paving a way to enter human trials on patients with diabetic foot ulcers.

Furthermore, AMS BioteQ’s dressing exhibits anti-inflammatory and antimicrobial effects on wounds. With a profile of high hydrophilicity and anti-adhesion, the dressing is fitted to use on wounds with all types of wound fluid.

Compared to using polyurethane or lyophilic colloids as the material, the dressing integrates gelatin which contains amino acids, which accelerates wound healing. 

Capturing the Boom in Pet Economy

 

As the pet economy grows with an exponential speed, dressings for animals become a lucrative battlefield. Currently, MEDIACE® has entered animal studies. It has been examined on animal models with Chlamydia, Aeromonas, Enterococcus faecalis, Pseudomonas, and E. coli. The result showed the dressing has an antimicrobial effect on those bacteria.

Now, the dressing is aimed at the human market, targeting decubitus ulcers, foot ulcers, infectious wounds, or hard-to-heal wounds caused by cancer.

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Novo Nordisk Acquire Catalent for $16.5 Billion, Enhancing Obesity Drugs Production Capacity
2024-02-07
AMS BioteQ Makes Debut at Medical Japan 2023: Bringing Innovative Healthcare into New Horizons
2023-10-24
Breaking Boundaries in Wound Care, AMS BioteQ at Medical Japan 2023
2023-10-03
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top